Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-033698
Filing Date
2025-03-05
Accepted
2025-03-05 16:30:25
Documents
2
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1617
2 EX-24.POA crnx-ex24_poa.htm EX-24.POA 17637
  Complete submission text file 0000950170-25-033698.txt   20681
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO CA 94080
Business Address
Schilke Tobin (Reporting) CIK: 0001678984 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38583 | Film No.: 25711674